Camlin Fine Sciences Ltd — Regulatory Filings 2021

Dec 30, 2021

==> picture [100 x 31] intentionally omitted <==

30[th] December, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**CompanyScripCode: 532834|To,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)

Sub: Intimation for closure of Trading Window

Pursuant to Clause 4 of the Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the clarification issued by National Stock Exchange of India Ltd. and BSE Ltd. dated April 2, 2019, the Trading Window for dealing in the shares of the Company shall remain closed from January 1, 2022 till 48 hours after the declaration of Unaudited Standalone and Consolidate financial results for the quarter ended December 31, 2021 for Insiders and Designated Employees.

The date of Board Meeting of the Company for consideration and declaration of the Unaudited Standalone and Consolidate Financial Results for the quarter ended December 31, 2021 will be intimated in due course.

We request you to take the above on record and disseminate the same on your website.

Thanking you, Yours faithfully, For Camlin Fine Sciences Limited Rahul Sawale Company Secretary & VP Legal

==> picture [426 x 57] intentionally omitted <==